Shimbo Daichi, Barrett Bowling C, Levitan Emily B, Deng Luqin, Sim John J, Huang Lei, Reynolds Kristi, Muntner Paul
From the Department of Medicine, Columbia University Medical Center, New York, NY (D.S.); Department of Veterans Affairs, Birmingham/Atlanta Geriatric Research, Education, and Clinical Center, Decatur, GA (C.B.B.); Emory University, Atlanta, GA (C.B.B.); Department of Epidemiology (E.B.L.), Department of Epidemiology (L.D.), Department of Epidemiology (L.H.), and Department of Epidemiology (P.M.), University of Alabama at Birmingham; Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA (J.J.S.); and Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA (K.R.).
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):222-9. doi: 10.1161/CIRCOUTCOMES.115.002524. Epub 2016 May 10.
Antihypertensive medication use has been associated with an increased risk of falls in some but not all studies. Few data are available on the short-term risk of falls after antihypertensive medication initiation and intensification.
We examined the association between initiating and intensifying antihypertensive medication and serious fall injuries in a case-crossover study of 90 127 Medicare beneficiaries who were ≥65 years old and had a serious fall injury between July 1, 2007, and December 31, 2012, based on emergency department and inpatient claims. Antihypertensive medication initiation was defined by a prescription fill with no fills in the previous year. Intensification was defined by the addition of a new antihypertensive class, and separately, titration by the addition of a new class or increase in dosage of a current class. Exposures were ascertained for the 15 days before the fall (case period) and six 15-day earlier periods (control periods). Overall, 272, 1508, and 3113 Medicare beneficiaries initiated, added a new class of antihypertensive medication or titrated therapy within 15 days of their serious fall injury. The odds for a serious fall injury was increased during the 15 days after antihypertensive medication initiation (odds ratio, 1.36 [95% confidence interval, 1.19-1.55]), adding a new class (odds ratio, 1.16 [95% confidence interval, 1.10-1.23]), and titration [odds ratio, 1.13 [95% confidence interval, 1.08-1.18]). These associations were attenuated beyond 15 days.
Antihypertensive medication initiation and intensification was associated with a short-term, but not long-term, increased risk of serious fall injuries among older adults.
在部分但并非所有研究中,使用抗高血压药物与跌倒风险增加相关。关于开始使用和强化抗高血压药物治疗后短期内的跌倒风险,可用数据较少。
我们在一项病例交叉研究中,调查了90127名年龄≥65岁且在2007年7月1日至2012年12月31日期间发生严重跌倒损伤的医疗保险受益人的抗高血压药物开始使用和强化治疗与严重跌倒损伤之间的关联,数据基于急诊科和住院患者索赔记录。抗高血压药物的开始使用定义为前一年无用药记录而此次有处方配药。强化治疗定义为添加新的抗高血压药物类别,单独来看,滴定定义为添加新类别或增加当前类别药物的剂量。在跌倒前15天(病例期)和六个提前15天的时间段(对照期)确定暴露情况。总体而言,272名、1508名和3113名医疗保险受益人在发生严重跌倒损伤的15天内开始使用、添加新的抗高血压药物类别或进行滴定治疗。在开始使用抗高血压药物后的15天内,发生严重跌倒损伤的几率增加(比值比,1.36 [95%置信区间,1.19 - 1.55]),添加新类别(比值比,1.16 [95%置信区间,1.10 - 1.23]),以及滴定治疗(比值比,1.13 [95%置信区间,1.08 - 1.18])。这些关联在15天后减弱。
在老年人中,开始使用和强化抗高血压药物治疗与短期内严重跌倒损伤风险增加相关,但与长期风险无关。